Your browser doesn't support javascript.
loading
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group.
Cseh, Annamaria M; Niemeyer, Charlotte M; Yoshimi, Ayami; Catala, Albert; Frühwald, Michael C; Hasle, Henrik; van den Heuvel-Eibrink, Mary M; Lauten, Melchior; De Moerloose, Barbara; Smith, Owen P; Bernig, Toralf; Gruhn, Bernd; Kulozik, Andreas E; Metzler, Markus; Olcay, Lale; Suttorp, Meinolf; Furlan, Ingrid; Strahm, Brigitte; Flotho, Christian.
Afiliação
  • Cseh AM; Division of Paediatric Haematology-Oncology, Department of Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany.
  • Niemeyer CM; Division of Paediatric Haematology-Oncology, Department of Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany.
  • Yoshimi A; Division of Paediatric Haematology-Oncology, Department of Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany.
  • Catala A; Hospital Sant Joan de Deu, Barcelona, Spain.
  • Frühwald MC; Swabian Children's Cancer Centre, Children's Hospital Augsburg, Augsburg, Germany.
  • Hasle H; Department of Paediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark.
  • van den Heuvel-Eibrink MM; Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands.
  • Lauten M; Department of Paediatrics, University Hospital Schleswig-Holstein, University of Lübeck, Lübeck, Germany.
  • De Moerloose B; Department of Paediatric Haematology-Oncology, Ghent University Hospital, Ghent, Belgium.
  • Smith OP; Trinity College and Department of Paediatric Haematology and Oncology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.
  • Bernig T; Department of Paediatrics, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
  • Gruhn B; Department of Paediatric Haematology and Oncology, Jena University Hospital, Children's Clinic, Jena, Germany.
  • Kulozik AE; Department of Paediatric Oncology, Haematology and Immunology, University of Heidelberg, Heidelberg, Germany.
  • Metzler M; Paediatric Haematology and Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Olcay L; Department of Paediatric Haematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital of the Ministry of Health, Ankara, Turkey.
  • Suttorp M; Division of Paediatric Haematology and Oncology, University Children's Hospital, Dresden, Germany.
  • Furlan I; University Children's Hospital, Ulm, Germany.
  • Strahm B; Division of Paediatric Haematology-Oncology, Department of Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany.
  • Flotho C; Division of Paediatric Haematology-Oncology, Department of Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany.
Br J Haematol ; 172(6): 930-6, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26766110
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Antimetabólitos Antineoplásicos Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Antimetabólitos Antineoplásicos Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido